Teligent Inc (TLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLGT | MGX | CPHI | ||
| Company | Teligent Inc | Metagenomi Therapeutics Inc | China Pharma Holdings | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 0.2070 | 1.6800 | 1.2500 | ||
| High | 0.2090 | 1.8000 | 1.2700 | ||
| Low | 0.1650 | 1.6500 | 1.2300 | ||
| Latest | 0.1735 | 1.7500 | 1.2550 | ||
| Change | -0.0279 | +0.1200 | +0.0250 | ||
| % Change | -13.85% | +7.36% | +2.03% | ||
| Volume | 73,687,200 | 515,400 | 3,312 | ||
| 20-Day Average Volume | 14,124,449 | 304,545 | 38,590 | ||
| Previous Close | 0.2014 | 1.6300 | 1.2300 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3321 | 1.7015 | 1.2793 | ||
| 20-Day Raw Stochastic | 3.24% | 60.71% | 18.10% | ||
| 20-Day Relative Strength | 25.55 | 49.17 | 41.48 | ||
| Weighted Alpha | -70.26 | -41.22 | -26.51 | ||
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -44.64% since 10/08/21 | +1.16% since 01/14/26 | +0.40% since 01/14/26 | ||
| Low | 0.1650 on 10/15/21 | 1.6000 on 01/20/26 | 1.1500 on 01/20/26 | ||
| High | 0.3388 on 10/13/21 | 1.8000 on 01/22/26 | 1.3200 on 01/21/26 | ||
| 1-Month | |||||
| %Chg | -55.68% since 09/15/21 | unch since 12/22/25 | -9.01% since 12/22/25 | ||
| Low | 0.1650 on 10/15/21 | 1.5800 on 12/31/25 | 1.1500 on 01/20/26 | ||
| High | 0.4275 on 09/30/21 | 1.8600 on 01/08/26 | 1.7300 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | -65.30% since 07/15/21 | -39.24% since 10/22/25 | -25.30% since 10/22/25 | ||
| Low | 0.1650 on 10/15/21 | 1.4700 on 11/21/25 | 1.1500 on 01/20/26 | ||
| High | 0.6300 on 08/04/21 | 2.9999 on 10/23/25 | 1.8800 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | -69.35% since 04/15/21 | -24.89% since 07/22/25 | -29.49% since 07/22/25 | ||
| Low | 0.1650 on 10/15/21 | 1.4700 on 11/21/25 | 1.1500 on 01/20/26 | ||
| High | 0.6579 on 06/14/21 | 3.9500 on 10/16/25 | 2.0299 on 09/09/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,104 | 61,202 | 6,177 | ||
| Shares Outstanding, K | 92,817 | 37,547 | 5,022 | ||
| Annual Sales | 45,310,000 | 52,300,000 | 4,530,000 | ||
| Annual Net Income | -122,020,000 | -78,060,000 | -4,740,000 | ||
| Last Quarter Sales | 10,430,000 | 8,660,000 | 760,000 | ||
| Last Quarter Net Income | -12,870,000 | -20,390,000 | -650,000 | ||
| 60-Month Beta | 1.61 | 0.50 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/16/21 | -0.55 on 11/11/25 | -0.17 on 11/12/25 | ||
| Latest Earnings Date | 10/03/22 | 03/16/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||